Format

Send to

Choose Destination
Drug Alcohol Depend. 2018 Jun 1;187:305-310. doi: 10.1016/j.drugalcdep.2018.02.025. Epub 2018 Apr 10.

Prevalence of alcohol use in pregnant women with substance use disorder.

Author information

1
Department of Pharmacy Practice and Administrative Sciences, College of Pharmacy, University of New Mexico, MSC09 5360, 1 University of New Mexico, Albuquerque, NM, 87131, USA; Department of Family and Community Medicine, School of Medicine, University of New Mexico, MSC09 5040, 1 University of New Mexico, Albuquerque, NM, 87131, USA. Electronic address: lbakhireva@salud.unm.edu.
2
Department of Pharmacy Practice and Administrative Sciences, College of Pharmacy, University of New Mexico, MSC09 5360, 1 University of New Mexico, Albuquerque, NM, 87131, USA.
3
Department of Family and Community Medicine, School of Medicine, University of New Mexico, MSC09 5040, 1 University of New Mexico, Albuquerque, NM, 87131, USA; Department of Obstetrics and Gynecology, School of Medicine, University of New Mexico, MSC10 5580, 1 University of New Mexico, Albuquerque, NM, 87131, USA.
4
Department of Obstetrics and Gynecology, School of Medicine, University of New Mexico, MSC10 5580, 1 University of New Mexico, Albuquerque, NM, 87131, USA.
5
The Mind Research Network, 1101 Yale Blvd. NE, Albuquerque, NM, 87106, USA; Lovelace Biomedical and Environmental Research Institute, 2425 Ridgecrest Dr. SE, Albuquerque, NM, 87108, USA.

Abstract

BACKGROUND:

Prenatal care programs for women with opioid use disorder (OUD) often focus treatment/counseling plans around illicit substances, while concurrent use of alcohol might present an equal or greater risk to the fetus.

METHODS:

This study evaluated self-reported prevalence of alcohol use in patients participating in a comprehensive prenatal care program for women with substance use disorder (SUD; n = 295), of which 95% are treated for OUD, and pregnant women being served through general obstetrical clinics at the University of New Mexico (n = 365). During the screening phase of a prospective study, patients were asked to report alcohol use in the periconceptional period, and between the last menstrual period and pregnancy recognition.

RESULTS:

The screening interview was conducted at 22.3 (median = 22; Q1 = 16; Q3 = 29) gestational weeks. Among patients screened at the SUD clinic, 28.8% and 24.1% reported at least one binge drinking episode in the periconceptional period and in early pregnancy, respectively. The prevalence of binge drinking was similar in the general obstetrics population (24.7% and 24.4%, respectively). Among those who reported drinking in early pregnancy, median number of binge drinking episodes was higher among patients screened at the SUD clinic (median = 3; Q1 = 1; Q3 = 10) compared to the general obstetrics group (median = 1; Q1 = 1; Q3 = 3; p < 0.001).

CONCLUSIONS:

This study demonstrates a high prevalence of prenatal alcohol use in early pregnancy in both groups, while patients with SUD/OUD consume more alcohol. These findings underscore the need for targeted screening and intervention for alcohol use in all pregnant women, especially those with SUD/OUD.

KEYWORDS:

Alcohol consumption; Opioid use disorder; Pregnancy; Prevalence

PMID:
29704852
PMCID:
PMC6298752
DOI:
10.1016/j.drugalcdep.2018.02.025
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center